{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T15:30:13Z","timestamp":1781019013613,"version":"3.54.1"},"reference-count":63,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,29]],"date-time":"2022-12-29T00:00:00Z","timestamp":1672272000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31872487"],"award-info":[{"award-number":["31872487"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2021YFC2600202"],"award-info":[{"award-number":["2021YFC2600202"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virologica Sinica"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.virs.2022.12.006","type":"journal-article","created":{"date-parts":[[2022,12,29]],"date-time":"2022-12-29T02:20:00Z","timestamp":1672280400000},"page":"244-256","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["An inactivated recombinant rabies virus chimerically expressed RBD induces humoral and cellular immunity against SARS-CoV-2 and RABV"],"prefix":"10.1016","volume":"38","author":[{"given":"Haili","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongli","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feihu","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumeng","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaxin","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cuicui","family":"Jiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujie","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingxuan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Di","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengyao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jilong","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingbo","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianzhu","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hualei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.virs.2022.12.006_bib1","doi-asserted-by":"crossref","first-page":"4223","DOI":"10.1038\/s41467-018-06741-w","article-title":"Non-neutralizing antibodies elicited by recombinant lassa-rabies vaccine are critical for protection against lassa fever","volume":"9","author":"Abreu-Mota","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.virs.2022.12.006_bib2","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s12250-017-3968-9","article-title":"Rabies virus co-localizes with early (Rab5) and late (Rab7) endosomal proteins in neuronal and SH-SY5Y cells","volume":"32","author":"Ahmad","year":"2017","journal-title":"Virol. Sin."},{"key":"10.1016\/j.virs.2022.12.006_bib3","doi-asserted-by":"crossref","first-page":"4782","DOI":"10.3390\/ijms21134782","article-title":"Immunopathology of SARS-CoV-2 infection: immune cells and mediators, prognostic factors, and immune-therapeutic implications","volume":"21","author":"Allegra","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.virs.2022.12.006_bib4","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0038630","article-title":"Immune responses to plague infection in wild rattus rattus, in Madagascar: a role in foci persistence?","volume":"7","author":"Andrianaivoarimanana","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.virs.2022.12.006_bib5","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.cytogfr.2007.01.016","article-title":"The relevance of cytokines for development of protective immunity and rational design of vaccines","volume":"18","author":"Chabalgoity","year":"2007","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.virs.2022.12.006_bib6","doi-asserted-by":"crossref","first-page":"e76","DOI":"10.1093\/cid\/ciac171","article-title":"Probable animal-to-human transmission of SARS-CoV-2 delta variant AY.127 causing a pet shop-related COVID-19 outbreak in Hong Kong","volume":"75","author":"Chan","year":"2022","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.virs.2022.12.006_bib7","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.3390\/v11121118","article-title":"In: Monophosphoryl-lipid a (mpla) Is an Efficacious Adjuvant for Inactivated Rabies Vaccines","volume":"11","author":"Chen","year":"2019","journal-title":"Viruses"},{"key":"10.1016\/j.virs.2022.12.006_bib8","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/s41591-022-01704-7","article-title":"Neutralizing antibodies against the SARS-CoV-2 Omicron variant BA.1 following homologous and heterologous coronavac or BNT162b2 vaccination","volume":"28","author":"Cheng","year":"2022","journal-title":"Nat. Med."},{"key":"10.1016\/j.virs.2022.12.006_bib9","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.823949","article-title":"Inactivated rabies virus vectored MERS-coronavirus vaccine induces protective immunity in mice, camels, and alpacas","volume":"13","author":"Chi","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.virs.2022.12.006_bib10","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0022-1759(97)00212-3","article-title":"Development of a fluorescent antibody virus neutralisation test (FAVN test) for the quantitation of rabies-neutralising antibody","volume":"212","author":"Cliquet","year":"1998","journal-title":"J.\u00a0Immunol. Methods"},{"key":"10.1016\/j.virs.2022.12.006_bib11","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/s41586-021-03739-1","article-title":"Age-related immune response heterogeneity to SARS-CoV-2 vaccine BNT162b2","volume":"596","author":"Collier","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.virs.2022.12.006_bib12","doi-asserted-by":"crossref","first-page":"e02077","DOI":"10.1128\/JVI.02077-16","article-title":"Inactivated recombinant rabies viruses displaying canine distemper virus glycoproteins induce protective immunity against both pathogens","volume":"91","author":"da Fontoura Budaszewski","year":"2017","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.virs.2022.12.006_bib13","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/s41577-020-00480-0","article-title":"Viral targets for vaccines against COVID-19","volume":"21","author":"Dai","year":"2021","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.virs.2022.12.006_bib14","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1126\/science.abc1932","article-title":"Development of an inactivated vaccine candidate for SARS-CoV-2","volume":"369","author":"Gao","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.virs.2022.12.006_bib15","doi-asserted-by":"crossref","first-page":"e348","DOI":"10.1016\/S2666-5247(22)00036-2","article-title":"SARS-CoV-2-specific antibody and T-cell responses 1 year after infection in people recovered from COVID-19: a longitudinal cohort study","volume":"3","author":"Guo","year":"2022","journal-title":"Lancet Microb."},{"key":"10.1016\/j.virs.2022.12.006_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109017","article-title":"SARS-CoV-2 mutations acquired in mink reduce antibody-mediated neutralization","volume":"35","author":"Hoffmann","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.virs.2022.12.006_bib17","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.ebiom.2017.09.028","article-title":"Cell-mediated immune predictors of vaccine effect on viral load and CD4 count in a phase 2 therapeutic HIV-1 vaccine clinical trial","volume":"24","author":"Huang","year":"2017","journal-title":"EBioMedicine"},{"key":"10.1016\/j.virs.2022.12.006_bib18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0009484","article-title":"An inactivated recombinant rabies virus displaying the Zika virus prM-E induces protective immunity against both pathogens","volume":"15","author":"Jin","year":"2021","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.virs.2022.12.006_bib19","first-page":"e2516","article-title":"A\u00a0bacterium-like particle vaccine displaying Zika virus prM-E induces systemic immune responses in mice","volume":"69","author":"Jin","year":"2022","journal-title":"Transbound. Emer. Dis."},{"key":"10.1016\/j.virs.2022.12.006_bib20","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.chom.2020.03.023","article-title":"Infection and rapid transmission of SARS-CoV-2 in ferrets","volume":"27","author":"Kim","year":"2020","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.virs.2022.12.006_bib21","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/s41541-020-00248-6","article-title":"Rabies virus-based COVID-19 vaccine coravaxTM induces high levels of neutralizing antibodies against SARS-CoV-2","volume":"5","author":"Kurup","year":"2020","journal-title":"NPJ Vacc."},{"key":"10.1016\/j.virs.2022.12.006_bib22","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1009383","article-title":"Inactivated rabies virus vectored SARS-CoV-2 vaccine prevents disease in a syrian hamster model","volume":"17","author":"Kurup","year":"2021","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.virs.2022.12.006_bib23","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.12073","article-title":"Neutralizing antibodies against the SARS-CoV-2 Omicron variant (BA.1) 1 to 18 weeks after the second and third doses of the BNT162b2 mrna vaccine","volume":"5","author":"Lassauniere","year":"2022","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.virs.2022.12.006_bib24","doi-asserted-by":"crossref","first-page":"125","DOI":"10.3390\/v12010125","article-title":"Characterization of the immune response of MERS-CoV vaccine candidates derived from two different vectors in mice","volume":"12","author":"Li","year":"2020","journal-title":"Viruses"},{"key":"10.1016\/j.virs.2022.12.006_bib25","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/s41392-022-00996-y","article-title":"COVID-19 vaccine development: milestones, lessons and prospects","volume":"7","author":"Li","year":"2022","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.virs.2022.12.006_bib26","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/s12964-020-00644-4","article-title":"Rabies virus phosphoprotein P5 binding to BECN1 regulates self-replication by BECN1-mediated autophagy signaling pathway","volume":"18","author":"Liu","year":"2020","journal-title":"Cell Commun. Signal."},{"key":"10.1016\/j.virs.2022.12.006_bib27","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.744242","article-title":"Understanding the secret of SARS-CoV-2 variants of concern\/interest and immune escape","volume":"12","author":"Lou","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.virs.2022.12.006_bib28","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jviromet.2019.04.025","article-title":"Development and validation of a real-time RT-PCR assay for the quantification of rabies virus as quality control of inactivated rabies vaccines","volume":"270","author":"Lourenc Correia Moreira","year":"2019","journal-title":"J.\u00a0Virol Methods"},{"key":"10.1016\/j.virs.2022.12.006_bib29","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.3390\/v12111324","article-title":"Application of viral vectors for vaccine development with a special emphasis on COVID-19","volume":"12","author":"Lundstrom","year":"2020","journal-title":"Viruses"},{"key":"10.1016\/j.virs.2022.12.006_bib30","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.ymthe.2019.01.020","article-title":"mRNA as a transformative technology for vaccine development to control infectious diseases","volume":"27","author":"Maruggi","year":"2019","journal-title":"Mol. Ther."},{"key":"10.1016\/j.virs.2022.12.006_bib31","doi-asserted-by":"crossref","first-page":"e02220","DOI":"10.1128\/mBio.02220-20","article-title":"From people to panthera: Natural SARS-CoV-2 infection in tigers and lions at the Bronx zoo","volume":"11","author":"McAloose","year":"2020","journal-title":"mBio"},{"key":"10.1016\/j.virs.2022.12.006_bib32","doi-asserted-by":"crossref","first-page":"10889","DOI":"10.1128\/JVI.77.20.10889-10899.2003","article-title":"Functional human immunodeficiency virus type 1 (HIV-1) gag-pol or HIV-1 gag-pol and env expressed from a single rhabdovirus-based vaccine vector genome","volume":"77","author":"McGettigan","year":"2003","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.virs.2022.12.006_bib33","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1093\/oxfordjournals.aje.a118408","article-title":"A\u00a0Simple Method of Estimating Fifty Percent Endpoints","volume":"27","author":"Muench","year":"1938","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.virs.2022.12.006_bib34","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/s41586-020-2639-4","article-title":"Phase I\/II study of COVID-19 RNA vaccine BNT162b1 in adults","volume":"586","author":"Mulligan","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.virs.2022.12.006_bib35","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1126\/science.abe5901","article-title":"Transmission of SARS-CoV-2 on mink farms between humans and mink and back to humans","volume":"371","author":"Munnink","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.virs.2022.12.006_bib36","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1080\/22221751.2020.1743767","article-title":"Establishment and validation of a pseudovirus neutralization assay for SARS-CoV-2","volume":"9","author":"Nie","year":"2020","journal-title":"Emerg. Microb. Infect."},{"key":"10.1016\/j.virs.2022.12.006_bib37","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1038\/s41467-020-15562-9","article-title":"Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV","volume":"11","author":"Ou","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.virs.2022.12.006_bib38","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0207295","article-title":"Deletion of a conserved transcript PG_RS02100 expressed during logarithmic growth in Porphyromonas gingivalis results in hyperpigmentation and increased tolerance to oxidative stress","volume":"13","author":"Phillips","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.virs.2022.12.006_bib39","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1038\/s41586-020-2814-7","article-title":"COVID-19 vaccine BNT162b1 elicits human antibody and Th1 T cell responses","volume":"586","author":"Sahin","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.virs.2022.12.006_bib40","doi-asserted-by":"crossref","first-page":"4195","DOI":"10.1002\/j.1460-2075.1994.tb06739.x","article-title":"Infectious rabies viruses from cloned cDNA","volume":"13","author":"Schnell","year":"1994","journal-title":"EMBO J."},{"key":"10.1016\/j.virs.2022.12.006_bib41","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1126\/science.abb7015","article-title":"Susceptibility of ferrets, cats, dogs, and other domesticated animals to SARS-coronavirus 2","volume":"368","author":"Shi","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.virs.2022.12.006_bib42","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/s41586-020-2381-y","article-title":"A\u00a0human neutralizing antibody targets the receptor-binding site of SARS-CoV-2","volume":"584","author":"Shi","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.virs.2022.12.006_bib43","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.jviromet.2009.05.018","article-title":"Development and evaluation of a rapid neutralizing antibody test for rabies","volume":"161","author":"Shiota","year":"2009","journal-title":"J.\u00a0Virol Methods"},{"key":"10.1016\/j.virs.2022.12.006_bib44","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.3201\/eid2807.212605","article-title":"Suspected cat-to-human transmission of SARS-CoV-2, Thailand, July-September 2021","volume":"28","author":"Sila","year":"2022","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.virs.2022.12.006_bib45","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/s41586-022-04865-0","article-title":"Limited cross-variant immunity from SARS-CoV-2 Omicron without vaccination","volume":"607","author":"Suryawanshi","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.virs.2022.12.006_bib46","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/j.cell.2021.01.037","article-title":"Circulating SARS-CoV-2 spike N439K variants maintain fitness while evading antibody-mediated immunity","volume":"184","author":"Thomson","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.virs.2022.12.006_bib47","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1038\/s41586-020-2608-y","article-title":"Chadox1 nCoV-19 vaccine prevents SARS-CoV-2 pneumonia in rhesus macaques","volume":"586","author":"van Doremalen","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.virs.2022.12.006_bib48","doi-asserted-by":"crossref","first-page":"4507","DOI":"10.4049\/jimmunol.164.9.4507","article-title":"Development of Th1-inducing capacity in myeloid dendritic cells requires environmental instruction","volume":"164","author":"Vieira","year":"2000","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.virs.2022.12.006_bib49","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3389\/fvets.2017.00009","article-title":"Elimination of dog-mediated human rabies deaths by 2030: needs assessment and alternatives for progress based on dog vaccination","volume":"4","author":"Wallace","year":"2017","journal-title":"Front. Vet. Sci."},{"key":"10.1016\/j.virs.2022.12.006_bib50","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s11262-014-1160-y","article-title":"Using rabies virus vaccine strain SRV9 as viral vector to express exogenous gene","volume":"50","author":"Wang","year":"2015","journal-title":"Virus Gene."},{"key":"10.1016\/j.virs.2022.12.006_bib52","doi-asserted-by":"crossref","first-page":"298","DOI":"10.3389\/fmicb.2020.00298","article-title":"Subunit vaccines against emerging pathogenic human coronaviruses","volume":"11","author":"Wang","year":"2020","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.virs.2022.12.006_bib53","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.3390\/v14061127","article-title":"Characterization of immune response diversity in rodents vaccinated with a vesicular stomatitis virus vectored COVID-19 vaccine","volume":"14","author":"Wang","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.virs.2022.12.006_bib54","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.61312","article-title":"Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants","volume":"9","author":"Weisblum","year":"2020","journal-title":"Elife"},{"issue":"Suppl. 2","key":"10.1016\/j.virs.2022.12.006_bib55","doi-asserted-by":"crossref","first-page":"S414","DOI":"10.1093\/infdis\/jiv251","article-title":"Preclinical development of inactivated rabies virus-based polyvalent vaccine against rabies and filoviruses","volume":"212","author":"Willet","year":"2015","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.virs.2022.12.006_bib56","doi-asserted-by":"crossref","first-page":"e02040","DOI":"10.1128\/JVI.02040-16","article-title":"One-health: a safe, efficient, dual-use vaccine for humans and animals against middle east respiratory syndrome coronavirus and rabies virus","volume":"91","author":"Wirblich","year":"2017","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.virs.2022.12.006_bib57","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1126\/science.abb2507","article-title":"Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation","volume":"367","author":"Wrapp","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.virs.2022.12.006_bib58","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S1473-3099(20)30831-8","article-title":"Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBIBP-CorV: a randomised, double-blind, placebo-controlled, phase 1\/2 trial","volume":"21","author":"Xia","year":"2021","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.virs.2022.12.006_bib59","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1016\/j.cell.2022.04.029","article-title":"Protective Prototype-Beta and Delta-Omicron Chimeric RBD-Dimer Vaccines against SARS-CoV-2","volume":"185","author":"Xu","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.virs.2022.12.006_bib60","article-title":"Characterization of two heterogeneous lethal mouse-adapted SARS-CoV-2 variants recapitulating representative aspects of human COVID-19","volume":"13","author":"Yan","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.virs.2022.12.006_bib61","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1038\/s41586-020-2599-8","article-title":"A\u00a0vaccine targeting the RBD of the S protein of SARS-CoV-2 induces protective immunity","volume":"586","author":"Yang","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.virs.2022.12.006_bib62","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1016\/S0140-6736(22)00326-9","article-title":"Transmission of SARS-CoV-2 Delta variant (AY.127) from pet hamsters to humans, leading to onward human-to-human transmission: a case study","volume":"399","author":"Yen","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.virs.2022.12.006_bib63","doi-asserted-by":"crossref","first-page":"919","DOI":"10.3390\/v11100919","article-title":"Genetically modified rabies virus vector-based rift valley fever virus vaccine is safe and induces efficacious immune responses in mice","volume":"11","author":"Zhang","year":"2019","journal-title":"Viruses"},{"key":"10.1016\/j.virs.2022.12.006_bib64","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S0140-6736(20)31605-6","article-title":"Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial","volume":"396","author":"Zhu","year":"2020","journal-title":"Lancet"}],"container-title":["Virologica Sinica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1995820X22002127?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1995820X22002127?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T19:19:32Z","timestamp":1761851972000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1995820X22002127"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":63,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["S1995820X22002127"],"URL":"https:\/\/doi.org\/10.1016\/j.virs.2022.12.006","relation":{},"ISSN":["1995-820X"],"issn-type":[{"value":"1995-820X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An inactivated recombinant rabies virus chimerically expressed RBD induces humoral and cellular immunity against SARS-CoV-2 and RABV","name":"articletitle","label":"Article Title"},{"value":"Virologica Sinica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virs.2022.12.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co. Ltd.","name":"copyright","label":"Copyright"}]}}